Impaired synaptic plasticity in behaving mice by inactivation of presenilin and accumulation of the neurexin gamma-secretase proteolytic substrate
Mutations in presenilin (PSEN1/2) genes are the main cause of familial Alzheimer's disease (fAD). Presenilin (PS) form the active component of the gamma-secretase complex, a protease that cleaves the C-terminal fragment (CTF) of multiple membrane proteins. The generation of mice lacking Psen1/2 genes in adult forebrain and of knockin mice expressing fAD-linked PSEN1 mutations favored a loss of function mechanism for PS/gamma-secretase in AD. In vitro, inactivation of PS impairs short- and long-term plasticity, but if PS regulates synaptic plasticity in vivo is not known, nor is it known the contribution of specific gamma-secretase substrates. In this study, we performed electrophysiological recordings at medial prefrontal cortex-basolateral (mPFC-BLA) synapse of behaving mice during fear conditioning, a type of associative memory. In controls, fear-conditioning decreases paired-pulse facilitation of the mPFC-BLA synapse, likely reflecting a memory-dependent increase in release probability. In contrast, PScKO<sup>tam</sup> mice lacking Psen1/2 genes in forebrain neurons in a tamoxifen-regulated manner show decreased paired-pulse facilitation at mPFC-BLA synapse along with impaired memory. Neurexins (Nrxns) are presynaptic membrane proteins processed by PS/gamma-secretase. Importantly, paired-pulse facilitation is further decreased in PScKO<sup>tam</sup>;NrxnCTF mice expressing increased NrxnCTF levels in PS-deficient neurons. Moreover, high-frequency stimulation induces long-term potentiation (LTP) at mPFC-BLA synapse of control mice, but LTP is impaired in PScKO<sup>tam</sup> mice and fully inhibited in PScKO<sup>tam</sup>;NrxnCTF mice. These findings suggest that PS enables learning-dependent adaptations in short and long-term synaptic plasticity by, at least in part, preventing the accumulation of NrxnCTF, pointing at NrxnCTF as a relevant factor downstream of PS dysfunction in AD.
Authors
- Ana C. Sánchez-Hidalgo (ORCID: https://orcid.org/0000-0003-4959-4826)
- José M. Delgado‐García (ORCID: https://orcid.org/0000-0001-7369-4195)
- Francisco Arias-Aragón (ORCID: https://orcid.org/0000-0002-6394-0193)
- Francisco G. Scholl (ORCID: https://orcid.org/0000-0003-1762-0700)
- Amalia Martı́nez-Mir (ORCID: https://orcid.org/0000-0002-1628-8972)
- Agnès Gruart (ORCID: https://orcid.org/0000-0002-2309-0323)
Institutions
- Instituto de Biomedicina de Sevilla (ES)
- Hospital Universitario Virgen del Rocío (ES)
- Universidad de Sevilla (ES)
- Universidad Pablo de Olavide (ES)
Publication Details
- Journal
- Experimental Neurology
- Published
- 2025-04-04
- DOI
- https://doi.org/10.1016/j.expneurol.2025.115241
- Primary Topic
- Neuroscience and Neuropharmacology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00